{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:52:02Z","timestamp":1761562322754,"version":"3.37.3"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32DK007066-42","K08-DK095951","K23-CA187185","R01-CA127334","R01-LM010098","K24-DK078228"],"award-info":[{"award-number":["5T32DK007066-42","K08-DK095951","K23-CA187185","R01-CA127334","R01-LM010098","K24-DK078228"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Observational studies analyzing multiple exposures simultaneously have been limited by difficulty distinguishing relevant results from chance associations due to poor specificity. Set-based methods have been successfully used in genomics to improve signal-to-noise ratio. We present and demonstrate medication class enrichment analysis (MCEA), a signal-to-noise enhancement algorithm for observational data inspired by set-based methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>We used The Health Improvement Network database to study medications associated with Clostridium difficile infection (CDI). We performed case-control studies for each medication in The Health Improvement Network to obtain odds ratios (ORs) for association with CDI. We then calculated the association of each pharmacologic class with CDI using logistic regression and MCEA. We also performed simulation studies in which we assessed the sensitivity and specificity of logistic regression compared to MCEA for ORs 0.1\u20132.0.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>When analyzing pharmacologic classes using logistic regression, 47 of 110 pharmacologic classes were identified as associated with CDI. When analyzing pharmacologic classes using MCEA, only fluoroquinolones, a class of antibiotics with biologically confirmed causation, and heparin products were associated with CDI. In simulation, MCEA had superior specificity compared to logistic regression across all tested effect sizes and equal or better sensitivity for all effect sizes besides those close to null.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Although these results demonstrate the promise of MCEA, additional studies that include inpatient administered medications are necessary for validation of the algorithm.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In clinical and simulation studies, MCEA demonstrated superior sensitivity and specificity for identifying pharmacologic classes associated with CDI compared to logistic regression.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jamia\/ocx162","type":"journal-article","created":{"date-parts":[[2017,12,31]],"date-time":"2017-12-31T12:07:08Z","timestamp":1514722028000},"page":"780-789","source":"Crossref","is-referenced-by-count":4,"title":["Medication class enrichment analysis: a novel algorithm to analyze multiple pharmacologic exposures simultaneously using electronic health record data"],"prefix":"10.1093","volume":"25","author":[{"given":"Ravy K","family":"Vajravelu","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank I","family":"Scott","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Division of Gastroenterology, Department of Medicine, University of Colorado Denver School of Medicine, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronac","family":"Mamtani","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhe","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason H","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, PA, USA"},{"name":"Institute for Biomedical Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"key":"2020110612363605700_ocx162-B1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/EDE.0b013e318228ca1d","article-title":"Commentary: what can we really learn from observational studies?","volume":"22","author":"Madigan","year":"2011","journal-title":"Epidemiology."},{"key":"2020110612363605700_ocx162-B2","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"2020110612363605700_ocx162-B3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet."},{"key":"2020110612363605700_ocx162-B4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-016-0289-9","article-title":"Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis","volume":"8","author":"Huang","year":"2016","journal-title":"Genome Med."},{"key":"2020110612363605700_ocx162-B5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1755-8794-6-34","article-title":"Pathway-based outlier method reveals heterogeneous genomic structure of autism in blood transcriptome","volume":"6","author":"Campbell","year":"2013","journal-title":"BMC Med Genomics."},{"key":"2020110612363605700_ocx162-B6","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler","year":"2015","journal-title":"N Engl J Med."},{"key":"2020110612363605700_ocx162-B7","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","article-title":"Use of gastric acid\u2013suppressive agents and the risk of community-acquired Clostridium difficile\u2013associated disease","volume":"294","author":"Dial","year":"2005","journal-title":"JAMA."},{"key":"2020110612363605700_ocx162-B8","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/cid\/civ432","article-title":"Use of acid suppression medication is associated with risk for C. difficile infection in infants and children: a population-based study","volume":"61","author":"Freedberg","year":"2015","journal-title":"Clin Infect Dis."},{"key":"2020110612363605700_ocx162-B9","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamainternmed.2013.7056","article-title":"Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011","volume":"173","author":"Chitnis","year":"2013","journal-title":"JAMA Intern Med."},{"journal-title":"Ann Intern Med.","article-title":"Increasing incidence of multiply recurrent clostridium difficile infection in the united states: a cohort study","author":"Ma","key":"2020110612363605700_ocx162-B10"},{"key":"2020110612363605700_ocx162-B11","volume-title":"Nonparametric Statistical Methods","author":"Hollander","year":"2013","edition":"3rd ed"},{"key":"2020110612363605700_ocx162-B12","volume-title":"Fundamentals of Biostatistics","author":"Rosner","year":"2011","edition":"7th ed"},{"key":"2020110612363605700_ocx162-B13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol."},{"volume-title":"R: A language and environment for statistical computing","year":"2017","author":"R Core Team","key":"2020110612363605700_ocx162-B14"},{"key":"2020110612363605700_ocx162-B15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/pds.3947","article-title":"Increasing use of prescription drugs in the United Kingdom","volume":"25","author":"Zhang","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"2020110612363605700_ocx162-B16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pds.1115","article-title":"The relationship between time since registration and measured incidence rates in the General Practice Research Database","volume":"14","author":"Lewis","year":"2005","journal-title":"Pharmacoepidemiol Saf."},{"key":"2020110612363605700_ocx162-B17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol."},{"key":"2020110612363605700_ocx162-B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2296-11-1","article-title":"Adaptation and validation of the Charlson Index for Read\/OXMIS coded databases","volume":"11","author":"Khan","year":"2010","journal-title":"BMC Fam Pract."},{"key":"2020110612363605700_ocx162-B19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/aje\/kwm069","article-title":"On the estimation and use of propensity scores in case-control and case-cohort studies","volume":"166","author":"M\u00e5nsson","year":"2007","journal-title":"Am J Epidemiol."},{"issue":"6","key":"2020110612363605700_ocx162-B20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3201\/eid0906.020385","article-title":"Fluoroquinolone use and Clostridium difficile\u2013associated ciarrhea","volume":"9","author":"McCusker","year":"2003","journal-title":"Emerg Infect Dis."},{"key":"2020110612363605700_ocx162-B21","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1128\/JCM.02482-09","article-title":"Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018","volume":"48","author":"Spigaglia","year":"2010","journal-title":"J Clin Microbiol."},{"key":"2020110612363605700_ocx162-B22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.gastro.2017.04.047","article-title":"Complications of proton pump inhibitor therapy","volume":"153","author":"Vaezi","year":"2017","journal-title":"Gastroenterology."},{"key":"2020110612363605700_ocx162-B23","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1038\/psp.2013.52","article-title":"Medication-wide association studies","volume":"2","author":"Ryan","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol."},{"key":"2020110612363605700_ocx162-B24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40264-015-0352-2","article-title":"Feasibility of prioritizing drug\u2013drug-event associations found in electronic health records","volume":"39","author":"Banda","year":"2016","journal-title":"Drug Saf."},{"key":"2020110612363605700_ocx162-B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/EDE.0000000000000638","article-title":"Biomedical informatics approaches to identifying drug-drug interactions","volume":"28","author":"Han","year":"2017","journal-title":"Epidemiology."},{"key":"2020110612363605700_ocx162-B26","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/606164","article-title":"Use of International Classification of Diseases, Ninth Revision Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection","volume":"30","author":"Schmiedeskamp","year":"2009","journal-title":"Infect Control Hosp Epidemiol."},{"key":"2020110612363605700_ocx162-B27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of The Health Improvement Network (THIN) database for pharmacoepidemiology research","volume":"16","author":"Lewis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"2020110612363605700_ocx162-B28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJMp1014427","article-title":"Developing the sentinel system \u2014 a national resource for evidence development","volume":"364","author":"Behrman","year":"2011","journal-title":"N Engl J Med."},{"key":"2020110612363605700_ocx162-B29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cpt.320","article-title":"The FDA\u2019s Sentinel initiative: a comprehensive approach to medical product surveillance","volume":"99","author":"Ball","year":"2016","journal-title":"Clin Pharmacol Ther."}],"container-title":["Journal of the American Medical Informatics Association"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jamia\/article-pdf\/25\/7\/780\/34150321\/ocx162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jamia\/article-pdf\/25\/7\/780\/34150321\/ocx162.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T06:18:59Z","timestamp":1719728339000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamia\/article\/25\/7\/780\/4825313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,1,25]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jamia\/ocx162","relation":{},"ISSN":["1067-5027","1527-974X"],"issn-type":[{"type":"print","value":"1067-5027"},{"type":"electronic","value":"1527-974X"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,1,25]]}}}